Prevalence of thrombotic complications in hospitalized COVID-19 patients in a medical ward in Japan: A single-center observational study

Prevalence of thrombotic complications in hospitalized COVID-19 patients in a medical ward in Japan: A single-center observational study - Prevalence of thrombotic complications in hospitalized COVID-19 patients in a medical ward in Japan: A single-center observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046003

Enrollment

1000

Registered

2021-11-07

Start date

2021-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were symptomatic and had diagnoses confirmed by nucleic acid tests or antigen tests for SARS-CoV-2 were eligible.

Exclusion criteria

Exclusion criteria: 1)Asymptomatic COVID-19 patients. 2)Clinically diagnosed COVID-19 patients who were not confirmed by tests for SARS-CoV-2.

Design outcomes

Primary

Measure	Time frame
The primary outcome was any thrombotic complication, which included venous thromboembolism, myocardial infarction, ischemic stroke, and other arterial embolisms.	—

Countries

Japan

Contacts

Public ContactNaoto Fukuda

National Hospital Organization Tochigi Medical Center Management Department

fukuda.naoto.hw@mail.hosp.go.jp028-622-5241

Outcome results